The dollar has softened against its peers amid a risk-on backdrop on global stock markets. News that University of Oxford/AstraZeneca resumed its phase-3 trial of its candidate vaccine for the coronavirus was taken as a buying cue for stock investors. That plus news of a batch of major merger activity. The USD index (DXY) dropped by 0.4% in pegging a low at 93.00, breaching below Friday’s low at 93.10 on route. EUR-USD lifted to a four-day peak at 1.1877. USD-JPY ebbed back under 106.00. Amid the dollar weakening theme was a pound rebounding theme.
For more info about this post: